Side-by-side comparison of AI visibility scores, market position, and capabilities
DTC fresh dog food subscription with vet-formulated human-grade meals customized to each dog; $85M+ backed competing with The Farmer's Dog and Mars-owned Nom Nom for premium pet food subscriptions.
Ollie is a New York-based direct-to-consumer fresh dog food company delivering human-grade, veterinarian-formulated meals customized to each dog's individual nutritional profile — shipping refrigerated fresh-cooked food directly to customers' doors on a subscription basis at price points significantly above traditional pet food brands but positioned as a health investment for pet owners seeking better nutrition than processed kibble. Founded in 2016 and backed by over $85 million from investors including Canaan Partners, Primary Venture Partners, and Companion Fund, Ollie competes in the premium fresh pet food segment that has grown substantially as pet humanization trends have driven premiumization.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.